Dianthus Therapeutics, Inc. (DNTH) Misses Q3 EPS by 349c
Tweet
Share
E-mailGet Alerts DNTH Hot Sheet
Join SI Premium – FREE
Dianthus Therapeutics, Inc. (NASDAQ: DNTH) reported Q3 EPS of ($3.78), $3.49 worse than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Dianthus Therapeutics, Inc. (DNTH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- Rithm Capital earns S&P upgrade to ’B+’ following steady revenue diversification
- B. Riley’s Top Biotech Picks Ahead of 3Q26 Earnings Season
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
